These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21383339)

  • 1. Efficacy of metabolic modulators in ischemic heart disease: an overview.
    Kalra BS; Roy V
    J Clin Pharmacol; 2012 Mar; 52(3):292-305. PubMed ID: 21383339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A; Lopaschuk GD
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W; Lopaschuk GD
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
    Lopaschuk GD
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Persistent" angina: rationale for a metabolic approach].
    Marzilli M
    Ital Heart J; 2004 Mar; 5 Suppl 2():37S-41S. PubMed ID: 15074776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of myocardial enzymes related to glycolysis and fatty acid metabolism in chronic myocardial ischemia: experiment with pigs].
    Gong J; Wang HY; Pu JL; Zheng YL; Shen R; Yang MF; He ZX
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2209-13. PubMed ID: 19080674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal shock wave therapy for ischemic cardiovascular disorders.
    Ito K; Fukumoto Y; Shimokawa H
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):295-302. PubMed ID: 21846155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic considerations in the treatment of coronary disease in diabetic patients].
    Piot C
    Diabetes Metab; 2001 Nov; 27(5 Pt 2):S25-9. PubMed ID: 11910982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart metabolic disturbances in cardiovascular diseases.
    Carvajal K; Moreno-Sánchez R
    Arch Med Res; 2003; 34(2):89-99. PubMed ID: 12700003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine.
    Skierczynska A; Beresewicz A
    J Physiol Pharmacol; 2010 Apr; 61(2):153-62. PubMed ID: 20436215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and resistant angina: is the metabolic approach an appropriate answer?
    Marzilli M
    Coron Artery Dis; 2004 May; 15 Suppl 1():S23-7. PubMed ID: 15179125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.